Literature DB >> 31076380

Respiratory support for infants with bronchiolitis, a narrative review of the literature.

Donna Franklin1, John F Fraser2, Andreas Schibler3.   

Abstract

Bronchiolitis is a common viral disease that significantly affects infants less than 12 months of age. The purpose of this review is to present a review of the current knowledge of the uses of respiratory support in the management of infants with bronchiolitis presenting to hospital. We electronically searched MEDLINE, Cochrane, CINAHL and EMBASE (inception to 25th March 2018), to manually search for clinical trials that address the management strategies for respiratory support of infants with bronchiolitis. We identified 120 papers who met the inclusion criteria, of which 33 papers were relevant for this review with only nine randomized controlled trials. This review demonstrated that non-invasive respiratory support reduced the need for escalation of therapy, particularly the proportion of intubations required for infants with bronchiolitis. Additionally, clear economic benefits have been demonstrated when non-invasive ventilation has been used. The potential early use of non-invasive respiratory supports such as nasal high flow therapy and non-invasive ventilation may have an impact on health care costs and reduction in ICU admissions and intubation rates. High-grade evidence demonstrates safety and quality of high flow therapy in general ward settings.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Bronchiolitis; Infant; Invasive mechanical ventilation; Nasal high flow; Non-invasive ventilation; Respiratory syncytial virus (RSV); Standard oxygen therapy

Mesh:

Year:  2018        PMID: 31076380     DOI: 10.1016/j.prrv.2018.10.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  7 in total

1.  Noninvasive ventilation of air transported infants with respiratory distress in the Canadian Arctic.

Authors:  Shelden D Roy; Fuad Alnaji; Deepti N Reddy; Nick J Barrowman; Holden A Sheffield
Journal:  Paediatr Child Health       Date:  2022-06-22       Impact factor: 2.600

2.  Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection.

Authors:  Jun Kubota; Sho Takahashi; Takayuki Suzuki; Akira Ito; Naoe Akiyama; Noriko Takahata
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

3.  Noninvasive ventilation for pediatric interfacility transports: a retrospective study.

Authors:  Samantha Holbird; Tanya Holt; Adam Shaw; Gregory Hansen
Journal:  World J Pediatr       Date:  2020-05-13       Impact factor: 2.764

4.  Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial.

Authors:  Michele Kong; Wei Wei Zhang; Kate Sewell; Gregory Gorman; Hui-Chien Kuo; Inmaculada Aban; Namasivayam Ambalavanan; Richard J Whitley
Journal:  JAMA Netw Open       Date:  2020-04-01

5.  High flow nasal cannula therapy versus continuous positive airway pressure and nasal positive pressure ventilation in infants with severe bronchiolitis: a randomized controlled trial.

Authors:  Aida Borgi; Assaad Louati; Narjess Ghali; Ahmed Hajji; Ahmed Ayari; Asma Bouziri; Mohamed Hssairi; Khaled Menif; Nejla Benjaballah
Journal:  Pan Afr Med J       Date:  2021-11-03

6.  De-escalation of High-flow Respiratory Support for Children Admitted with Bronchiolitis: A Quality Improvement Initiative.

Authors:  Jennifer A Hoefert; Adolfo L Molina; Hannah M Gardner; Kevin H Miller; Chang L Wu; Karisa Grizzle
Journal:  Pediatr Qual Saf       Date:  2022-03-30

7.  Urgent air transfers for acute respiratory infections among children from Northern Canada, 2005-2014.

Authors:  Caitlin Prendergast; Joan Robinson; Chelsea Caya; Maria E Perez Trejo; Iline Guan; Veronica Hébert-Murakami; Justina Marianayagam; Zing-Wae Wong; Celia Walker; David M Goldfarb; Nick Barrowman; Radha Jetty; Joanne Embree; Jesse Papenburg
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.